Prescription drug savings from Pfizer

In today’s world, access to affordable healthcare is a pressing concern for many individuals. Pfizer, a renowned pharmaceutical company, recognizes the importance of ensuring patients have access to their needed medications. For over 30 years, Pfizer RxPathways has been a vital program that connects eligible patients in the United States to various assistance programs offered by Pfizer. These programs provide insurance support, co-pay help, and access to medications for free or at a reduced cost. This article explores the comprehensive services provided by Pfizer RxPathways, its impact on patient care, and how eligible individuals can benefit from this program.

The importance of accessible healthcare

Access to affordable healthcare is a fundamental right that should be available to all individuals. However, financial barriers and high prescription drug costs often prevent people from obtaining the necessary medications for their well-being. Pfizer understands this challenge and has developed RxPathways as an initiative to support patients in need. By providing access to assistance programs, Pfizer aims to alleviate financial burdens and ensure that patients can receive the prescription drugs prescribed to them.

Pfizer RxPathways Assistance Programs

Pfizer RxPathways offers a range of assistance programs designed to address the diverse needs of patients. These programs include insurance support, co-pay help, and access to medications for free or at a savings. The program collaborates with healthcare providers and office staff to streamline the application process, making it easier for patients to enroll and receive the support they need.

Insurance support

Navigating the complexities of insurance coverage can be overwhelming for patients. Pfizer RxPathways assists patients in understanding their insurance options and provides support in accessing the medications covered by their plans. Through partnerships with various insurance providers, RxPathways ensures that patients can access the medications they need without facing excessive financial burdens.

Co-pay help

High co-pays can be a significant barrier for patients, especially for those with chronic conditions requiring ongoing medication. Pfizer RxPathways offers co-pay assistance programs that help reduce or eliminate out-of-pocket costs for eligible patients. This financial support ensures that individuals can afford their medications and continue their treatment without interruption.

Free or reduced-cost medications

For patients facing financial hardship, the cost of medications can be prohibitive. Pfizer RxPathways provides access to Pfizer medications either for free or at a reduced cost, depending on the patient’s eligibility. This financial assistance is invaluable for individuals who may not have access to other financial resources or insurance coverage.

Eligibility criteria

To qualify, patients must meet the eligibility criteria:

• Have a valid prescription from a healthcare professional for the Pfizer medicine, available in the PAP, for which they are seeking assistance
• Have an FDA-approved indication for the requested product(s)
• Be uninsured or government-insured and unable to afford their copayment. Commercially insured patients are not eligible
• Meet income guidelines, which vary by medicine, but start at 300% of the Federal Poverty Level, adjusted for family size
• Reside in the U.S. or a U.S. territory
• Be treated by a healthcare provider licensed in the U.S. or a U.S. territory

Available medicines

Pfizer Patient Assistance Program Medications provides eligible patients with the following Pfizer medicines for free:

• AROMASIN® (exemestane) tablets
• ARTHROTEC® (diclofenac sodium/misoprostol) tablets
• BeneFIX® Coagulation Factor IX (Recombinant)
• BESPONSA™ (inotuzumab ozogamicin, for injection, for intravenous use)
• BOSULIF® (bosutinib) tablets
• CAMPTOSAR® (irinotecan hydrochloride) injection
• CELONTIN® (methsuximide) capsules
• USP CHANTIX® (varenicline) tablets
• CLEOCIN® (clindamycin)
• DAURISMO™ (glasdegib) tablets
• DEPO-PROVERA® (medroxyprogesterone acetate injectable suspension)
• DEPO-SUBQ PROVERA 104® (medroxyprogesterone acetate) injectable suspension
• DEPO®-ESTRADIOL (estradiol cypionate) injection
• USP DUAVEE™ (conjugated estrogens/bazedoxifene) tablets
• ELELYSO™ (taliglucerase alfa) for injection
• ELLENCE® (epirubicin hydrochloride injection)
• EMCYT® (estramustine phosphate sodium) capsules
• ESTRING® (estradiol vaginal ring)
• EUCRISA® (crisaborole) ointment, 2%
• FELDENE® (piroxicam) capsules
• FRAGMIN® (dalteparin sodium) injection
• GENOTROPIN® (somatropin) for injection
• HEPARIN Sodium Injection, USP
• IBRANCE® (palbociclib) capsules
• IDAMYCIN PFS® (idarubicin hydrochloride) injection
• INFLECTRA® (infliximab-dyyb) for injection
• INLYTA® (axitinib) tablets
• LEVOXYL® (levothyroxine sodium) tablets
• LINCOCIN® (lincomycin) injection, USP
• MENEST® (esterified estrogens) tablets, USP
• MYCOBUTIN® (rifabutin) capsules,
• USP MYLOTARG™ (gemtuzumab ozogamicin) for injection
• NICOTROL® (nicotine)
• NIVESTYM® (filgrastim-aafi) injection
• NORPACE® (disopyramide phosphate)
• PREMARIN® (conjugated estrogens) Vaginal Cream
• PREMARIN® (conjugated estrogens) tablets, USP
• PREMPHASE® (conjugated estrogens plus medroxyprogesterone acetate) tablets
• PREMPRO® (conjugated estrogens/medroxyprogesterone acetate) tablets
• PREVNAR 13® Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]
• PRISTIQ® (desvenlafaxine) extended-release tablets
• RAPAMUNE® (sirolimus)
• RAPAMUNE® (sirolimus) oral suspension
• RETACRIT® (epoetin alfa-epbx) injection
• SKELAXIN® (metaxalone) tablets
• SOMAVERT® (pegvisomant) for injection
• SUTENT® (sunitinib malate) capsules
• SYNAREL® (nafarelin acetate) nasal solution
• TALZENNA® (talazoparib) capsules
• TIKOSYN® (dofetilide) capsules
• TORISEL® (temsirolimus) injection
• TOVIAZ® (fesoterodine fumarate) extended-release tablets
• TRECATOR® (ethionamide) tablets
• TRUMENBA® (Meningococcal Group B Vaccine)
• TYGACIL® (tigecycline) for injection
• VFEND® (voriconazole)
• VIZIMPRO® (dacomitinib) tablets
• VYNDAQEL® (tafamidis meglumine) capsules
• XALKORI® (crizotinib) capsules
• XELJANZ® (tofacitinib) tablets
• XELJANZ® (tofacitinib) oral solution
• XELJANZ® XR (tofacitinib) extended-release tablets
• XYNTHA® Antihemophilic Factor (Recombinant)
• ZARONTIN® (ethosuximide) ZYVOX® (linezolid)

The Pfizer Savings Program helps uninsured patients access the following Pfizer medicines at a saving through their local retail pharmacy, regardless of income:

• ACCURETIC™ (quinapril HCl/hydrochlorothiazide) tablets
• ALDACTAZIDE® (spironolactone/hydrochlorothiazide)
• ALDACTONE® (spironolactone) tablets
• ALTACE® (ramipril)
• AROMASIN® (exemestane) tablets
• ARTHROTEC® (diclofenac sodium/misoprostol) tablets
• ATGAM® (lymphocyte immune globulin, anti-thymocyte globulin [equine] sterile solution)
• BACITRACIN for Injection, USP
• BOSULIF® (bosutinib) tablets
• CALAN® (verapamil hydrochloride) tablets
• CELONTIN® (methsuximide) capsules, USP
• CHANTIX® (varenicline) tablets
• CLEOCIN® (clindamycin)
• COLESTID® (micronized colestipol hydrochloride)
• CORTEF® (hydrocortisone tablets)
• CORVERT® (ibutilide fumarate injection)
• CYKLOKAPRON® (tranexamic acid) injection
• CYTOMEL® (liothyronine sodium) tablets
• CYTOTEC® (misoprostol) tablets
• DAURISMO™ (glasdegib) tablets
• DAYPRO® (oxaprozin)
• DEPO-MEDROL® (methylprednisolone acetate injectable suspension)
• DEPO-PROVERA® (medroxyprogesterone acetate injectable suspension)
• DEPO-SUBQ PROVERA 104® (medroxyprogesterone acetate) injectable suspension
• DEPO®-ESTRADIOL (estradiol cypionate) injection, USP
• DEPO®-TESTOSTERONE CIII (testosterone cypionate) injection, USP
• DIFLUCAN® (fluconazole)
• DUAVEE™ (conjugated estrogens/bazedoxifene) tablets
• ELLENCE® (epirubicin hydrochloride injection)
• EMCYT® (estramustine phosphate sodium) capsules
• ERAXIS™ (anidulafungin) for injection
• ESTRING® (estradiol vaginal ring)
• FELDENE® (piroxicam) capsules
• FLAGYL® (metronidazole) tablets
• GLUCOTROL® (glipizide) tablets
• GLYNASE® PRESTAB® (micronized glyburide)
• HALCION® (triazolam) tablets, USP CIV
• HEMABATE® (carboprost tromethamine) injection, USP
• IBRANCE® (palbociclib) capsules
• IDAMYCIN PFS® (idarubicin hydrochloride) injection
• INLYTA® (axitinib) tablets
• LEVOXYL® (levothyroxine sodium) tablets
• LINCOCIN® (lincomycin) injection, USP
• LOMOTIL® (diphenoxylate hydrochloride/atropine sulfate)
• LOPID® (gemfibrozil) tablets, USP
• MEDROL® (methylprednisolone) tablets, USP
• MENEST® (esterified estrogens) tablets, USP
• MYCOBUTIN® (rifabutin) capsules, USP
• NICOTROL® (nicotine)
• NIVESTYM® (filgrastim-aafi) injection
• NORPACE® (disopyramide phosphate)
• PFIZERPEN® (penicillin G potassium) for injection
• PREMARIN® (conjugated estrogens) Vaginal Cream
• PREMARIN® (conjugated estrogens) tablets, USP
• PREMPHASE® (conjugated estrogens plus medroxyprogesterone acetate) tablets
• PREMPRO® (conjugated estrogens/medroxyprogesterone acetate) tablets
• PRISTIQ® (desvenlafaxine) extended-release tablets
• PROCARDIA® (nifedipine)
• PROCARDIA® XL (nifedipine)
• PROTONIX® (pantoprazole sodium)
• PROVERA® (medroxyprogesterone acetate) tablet, USP
• R-GENE® 10 Arginine Hydrochloride Injection, USP
• RAPAMUNE® (sirolimus)
• RAPAMUNE® (sirolimus) oral suspension
• SKELAXIN® (metaxalone) tablets
• SOMAVERT® (pegvisomant) for injection
• SONATA® (zaleplon) Capsules CIV
• SUTENT® (sunitinib malate) capsules
• SYNAREL® (nafarelin acetate) nasal solution
• TALZENNA® (talazoparib) capsules
• TESSALON® (benzonatate) capsules, USP
• TIKOSYN® (dofetilide) capsules
• TOVIAZ® (fesoterodine fumarate) extended-release tablets
• TRECATOR® (ethionamide) tablets
• VFEND® (voriconazole)
• VIZIMPRO® (dacomitinib) tablets
• XALKORI® (crizotinib) capsules
• XELJANZ® (tofacitinib) tablets
• XELJANZ® (tofacitinib) oral solution
• XELJANZ® XR (tofacitinib) extended-release tablets
• ZARONTIN® (ethosuximide)
• ZITHROMAX® (azithromycin for injection) for IV infusion only
• ZMAX® (azithromycin) extended-release for oral suspension
• ZYVOX® (linezolid)

Pfizer Dermatology Patient Access™ Program

In addition to the comprehensive services provided by Pfizer RxPathways, Pfizer also offers specialized support through the Pfizer Dermatology Patient Access™ program. This program is specifically designed to provide savings and support resources for patients seeking access to Pfizer dermatology medications prescribed by their healthcare providers. The Pfizer Dermatology Patient Access™ program aims to remove financial barriers and ensure that patients can obtain the dermatology medications they require for optimal skin health.

How to Access Pfizer RxPathways and Pfizer Dermatology Patient Access™

To access the services provided by Pfizer RxPathways and the Pfizer Dermatology Patient Access™ program, patients and healthcare providers can utilize various channels. The official website of Pfizer RxPathways (www.pfizerrxpathways.com) offers detailed information on the programs, eligibility requirements, and the enrollment process. Individuals can also call the toll-free phone number 1-844-989-PATH (7284) to consult with a Pfizer Medicine Access Counselor who can provide guidance and support.

For those specifically seeking support for dermatology medications, the Pfizer Dermatology Patient Access™ program can be accessed through the website (www.pfizerdermatologypatientaccess.com/hcp) or by calling 1-833-956-DERM (3376).

Conclusion

Access to affordable healthcare is a critical aspect of ensuring the well-being of individuals. Pfizer RxPathways has been at the forefront of addressing this issue by connecting eligible patients to assistance programs that provide insurance support, co-pay help, and access to medications for free or at a saving. Through these initiatives, Pfizer has made a significant impact on patient care, helping millions of Americans receive the medications they need. The testimonials from grateful patients serve as a testament to the transformative power of RxPathways. By continuing to prioritize accessibility and affordability, Pfizer demonstrates its commitment to improving the lives of patients across the United States.

For more information on Pfizer RxPathways and the Pfizer Dermatology Patient Access™ program, visit the official websites or contact the provided phone numbers. Pfizer remains dedicated to supporting needy patients and ensuring that healthcare is accessible to all.

Sources

• Available medications English PDF (pfizerrxpathways.com)
• Patient Assistance | Pfizer For Professionals (pfizerpro.com)
• For Patients – Pfizer RxPathways